Insider Stock Trading History of Kremer Alton B


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kremer Alton B since year 2005. The trader's CIK number is 1327416. At the time of this reporting, Kremer Alton B is the VP, Clinical Researc of Progenics Pharmaceuticals Inc . (stock ticker symbol PGNX). See this page for all insider trading activities at Progenics Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Kremer Alton B since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 3,153 6.52 20,557
2008-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 1,139 15.36 17,495
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,328 19.03 44,301
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,328 19.03 44,301
2007-07-02 PGNX Progenics Pharmaceuticals Inc Option Ex 852 18.71 15,940
2007-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 686 21.88 15,009
2006-10-02 PGNX Progenics Pharmaceuticals Inc Option Ex 752 19.58 14,724
2006-07-03 PGNX Progenics Pharmaceuticals Inc Option Ex 2,262 20.45 46,260
2006-06-21 PGNX Progenics Pharmaceuticals Inc Sale 875 21.60 18,900
2006-04-03 PGNX Progenics Pharmaceuticals Inc Option Ex 611 21.77 13,300
2006-01-30 PGNX Progenics Pharmaceuticals Inc Option Ex 8,000 13.57 108,560
2006-01-30 PGNX Progenics Pharmaceuticals Inc Sale 8,000 27.63 221,064
2006-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 659 20.86 13,746

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kremer Alton B (VP, Clinical Researc of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.